Press Releases

Health care antitrust leader joins Hogan Lovells in Washington, D.C., strengthening global antitrust capabilities

Washington, D.C., 15 March 2023 – Global law firm Hogan Lovells is pleased to announce that Kenneth W. Field has joined the firm as leader of the health care antitrust practice and a...

Awards and Rankings

LMG Life Sciences recognizes Hogan Lovells as Regulatory Firm of the Year for 2022

Hogan Lovells is pleased to announce that it was named Regulatory Firm of the Year for the fourth time at the LMG Life Sciences annual awards event for 2022, with Janice Hogan named as the...

Press Releases

Former Deputy Chief of the Criminal Division, Southern District of New York Kristy Greenberg joins Hogan Lovells' New York office as partner

New York, 12 September 2022 – Global law firm Hogan Lovells announced today that Kristy Greenberg has joined the firm as a litigation and investigations partner in New York. Greenberg ...

Announcements

Hogan Lovells' Cybil Roehrenbeck reps Healthcare AI Coalition on Congressional Healthy Futures Task Force rollout

Global law firm Hogan Lovells’ government affairs & healthcare technology partner Cybil Roehrenbeck participated in a roundtable with U.S. Representatives Mariannette Miller Meeks ...

Awards and Rankings

Kristin Connarn named to MA Lawyers Weekly's Go-To Lawyers for Life Sciences/Health Care list

Global law firm Hogan Lovells is pleased to announce that Kristin Connarn, a Boston-based life sciences partner in the Intellectual Property, Media, and Technology (IPMT) practice, has been ...

Press Releases

Hogan Lovells welcomes the New Year with 27 new partner and 71 new counsel promotions

London and Washington, D.C., 5 January 2022 – Global law firm Hogan Lovells today announced that 27 of its people have been promoted to partner effective 1 January across a network of ...

Press Releases

Hogan Lovells advises Valneva regarding its purchase agreement with Bahrain for its inactivated Covid-19 vaccine candidate, VLA2001

Hogan Lovells has advised Valneva on the preparation and signing of an advanced purchase agreement with Bahrain for its Covid-19 inactivated vaccine candidate, VLA2001.

Press Releases

Hogan Lovells advises Valneva regarding its purchase agreement with the European Commission for its Inactivated Covid-19 Vaccine Candidate VLA2001

Hogan Lovells advised Valneva regarding the signing of an Advanced Purchase Agreement (APA) with the European Commission for its Inactivated Covid-19 Vaccine Candidate , VLA2001.

Loading data